Product Information
DULOXETINE HCL DR 40 MG CAP is a generic product labeled by BluePoint Laboratories, priced at $1.0477 per EA under NDC 68001036804. Its NADAC has been published 374 times since Feb 6, 2019.
Strength
40 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001036804
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Last Updated
3/18/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203088On Market Since
5/21/2018
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 40 MG CAP has been published 374 times since Feb 6, 2019, and over the history we have for it it has declined 66.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0477 per EA |
|---|---|
| All-time high | $3.1127 (Oct 16, 2019) |
| All-time low | $0.9547 (Jul 17, 2024) |
| 52-week high | $1.4045 |
| 52-week low | $1.0477 |
| Median price | $1.7575 |
| Average price | $1.8691 |
| Largest weekly change | +46.1% (Aug 21, 2024) |
| Weeks tracked | 374 |
| Tracking since | Feb 6, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 40 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 40 MG CAP, manufactured by BluePoint Laboratories, is $1.0477 per EA (NDC 68001036804), effective Apr 1, 2026.
How has the price of DULOXETINE HCL DR 40 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 40 MG CAP has declined 66.1%. It has been tracked across 374 weekly CMS publications since Feb 6, 2019.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 40 MG CAP?
Since Feb 6, 2019, the NADAC for DULOXETINE HCL DR 40 MG CAP has ranged from a low of $0.9547 (Jul 17, 2024) to a high of $3.1127 (Oct 16, 2019), with a median of $1.7575 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 40 MG CAP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as DULOXETINE HCL DR 40 MG CAP, but none are currently priced below it.
Who manufactures DULOXETINE HCL DR 40 MG CAP?
DULOXETINE HCL DR 40 MG CAP (NDC 68001036804) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification